Exploratory Study to Assess the Biological Activity of ZD6126 in Subjects With Newly Diagnosed Metastatic Renal Cell Carcinoma (Stage IV)
Clinical trial NCT00065572 · SUSPENDED
Trial details
- NCT number
- NCT00065572
- Sponsor
- AstraZeneca
- Status
- SUSPENDED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-08-01
- Primary completion
- 2004-02-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.